Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity

Acetylcholinesterase (AChE) inhibitors are widely used for the symptomatic treatment of Alzheimer’s disease and other dementias. More recent use is for myasthenia gravis. Many of these inhibitors interact with the second known cholinesterase, butyrylcholinesterase (BChE). Further, evidence shows tha...

Full description

Bibliographic Details
Main Author: Miroslav Pohanka
Format: Article
Language:English
Published: MDPI AG 2014-06-01
Series:International Journal of Molecular Sciences
Subjects:
cholinergic anti-inflammatory pathway
acetylcholinesterase
butyrylcholinesterase
Alzheimer disease
neuroimmunity
neuromodulation
Online Access:http://www.mdpi.com/1422-0067/15/6/9809

Internet

http://www.mdpi.com/1422-0067/15/6/9809

Similar Items